Scotiabank Issues Pessimistic Forecast for Quanterix (NASDAQ:QTRX) Stock Price
Quanterix (NASDAQ:QTRX – Get Free Report) had its target price cut by Scotiabank from $28.00 to $18.00 in a research note ...
360dx20d
Neurology Blood Tests Primed to Improve Diagnosis, Management of Patients in Alzheimer's and Beyond
High-sensitivity immunoassay firm Quanterix, for instance, applied its Simoa technology to measuring blood-based neurology markers like neurofilament light chain (NfL) as well as Alzheimer's-linked ...
Frontiers19d
Association between cognitive functioning and microbiota-gut-brain axis mediators in a memory clinic population
(NF-Light immunoassay Advantage kit; Cat. No. 103400), glial fibrillary acidic protein (GFAP) (GFAP Human Discovery Kit; Cat. No. 102336), and p-tau181 (p-tau181 V2 Advantage Kit; Cat. No. 103714) ...
Quanterix Corporation (NASDAQ:QTRX) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 17, 2025 Quanterix Corporation misses on earnings expectations. Reported EPS is $-0.3 ...
Business Wire27d
Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX) (“Quanterix” or the “Company”), a company fueling scientific discovery through ultra ...